Table 1.
The antitumor drugs targeting the PD-L1 trafficking
| Drugs or therapy | Regulatory signal | References | 
|---|---|---|
| SA-49 | PKCα/GSK3β/MITF | [47] | 
| TBM-1 | TFEB | [49] | 
| IPAG | Sigma 1 | [44] | 
| 2-BP | DHHC3 | [45] | 
| PD-LYSO | HIP1R | [46] | 
| STM108 | EGFR/B3GNT3 | [51] | 
| H1A | CMTM6 | [43] | 
| Verteporfen | Palmitoylation, glycosylation | [52] | 
| Curcumin | Palmitoylation, glycosylation\STAT\proteasome | [123] | 
| Pitstop 2 | Recycle | [124] | 
| Ivermectin | Changes in redistribution, macromolecular interactions | [125] | 
| Diformin | Isolation of PD-L1 in endosomes or autophagosomes | [126] | 
| Amlodipine | Target PD-L1 to lysosome | [127] | 
| LYTAC | Lysosomal targeting chimaera, extracellular proteins | [128] |